CYP26B1 has been shown to be over-expressed in colorectal cancer cells compared to normal colonicepithelium. CYP26B1 expression was also independently prognostic in patients with colorectal cancer and strong expression was associated with a poorer outcome.[3]
References
↑Nelson DR (Dec 1999). "A second CYP26 P450 in humans and zebrafish: CYP26B1". Arch Biochem Biophys. 371 (2): 345–7. doi:10.1006/abbi.1999.1438. PMID10545224.
Rat E, Billaut-Laden I, Allorge D, et al. (2006). "Evidence for a functional genetic polymorphism of the human retinoic acid-metabolizing enzyme CYP26A1, an enzyme that may be involved in spina bifida". Birth Defects Res. Part a Clin. Mol. Teratol. 76 (6): 491–8. doi:10.1002/bdra.20275. PMID16933217.
Bowles J, Knight D, Smith C, et al. (2006). "Retinoid signaling determines germ cell fate in mice". Science. 312 (5773): 596–600. doi:10.1126/science.1125691. PMID16574820.
Hillier LW, Graves TA, Fulton RS, et al. (2005). "Generation and annotation of the DNA sequences of human chromosomes 2 and 4". Nature. 434 (7034): 724–31. doi:10.1038/nature03466. PMID15815621.